Literature DB >> 9759484

Modified oligonucleotides: synthesis and strategy for users.

S Verma1, F Eckstein.   

Abstract

Synthetic oligonucleotide analogs have greatly aided our understanding of several biochemical processes. Efficient solid-phase and enzyme-assisted synthetic methods and the availability of modified base analogs have added to the utility of such oligonucleotides. In this review, we discuss the applications of synthetic oligonucleotides that contain backbone, base, and sugar modifications to investigate the mechanism and stereochemical aspects of biochemical reactions. We also discuss interference mapping of nucleic acid-protein interactions; spectroscopic analysis of biochemical reactions and nucleic acid structures; and nucleic acid cross-linking studies. The automation of oligonucleotide synthesis, the development of versatile phosphoramidite reagents, and efficient scale-up have expanded the application of modified oligonucleotides to diverse areas of fundamental and applied biological research. Numerous reports have covered oligonucleotides for which modifications have been made of the phosphodiester backbone, of the purine and pyrimidine heterocyclic bases, and of the sugar moiety; these modifications serve as structural and mechanistic probes. In this chapter, we review the range, scope, and practical utility of such chemically modified oligonucleotides. Because of space limitations, we discuss only those oligonucleotides that contain phosphate and phosphate analogs as internucleotidic linkages.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9759484     DOI: 10.1146/annurev.biochem.67.1.99

Source DB:  PubMed          Journal:  Annu Rev Biochem        ISSN: 0066-4154            Impact factor:   23.643


  60 in total

1.  Selecting rRNA binding sites for the ribosomal proteins L4 and L6 from randomly fragmented rRNA: application of a method called SERF.

Authors:  U Stelzl; C M Spahn; K H Nierhaus
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

Review 2.  Survey and summary: The applications of universal DNA base analogues.

Authors:  D Loakes
Journal:  Nucleic Acids Res       Date:  2001-06-15       Impact factor: 16.971

3.  A short fragment of 23S rRNA containing the binding sites for two ribosomal proteins, L24 and L4, is a key element for rRNA folding during early assembly.

Authors:  U Stelzl; K H Nierhaus
Journal:  RNA       Date:  2001-04       Impact factor: 4.942

4.  Kinetic and binding analysis of the catalytic involvement of ribose moieties of a trans-acting delta ribozyme.

Authors:  Karine Fiola; Jean-Pierre Perreault
Journal:  J Biol Chem       Date:  2002-05-15       Impact factor: 5.157

5.  Delta ribozyme benefits from a good stability in vitro that becomes outstanding in vivo.

Authors:  Dominique Lévesque; Sanaa Choufani; Jean-Pierre Perreault
Journal:  RNA       Date:  2002-04       Impact factor: 4.942

6.  RNA-structural mimicry in Escherichia coli ribosomal protein L4-dependent regulation of the S10 operon.

Authors:  Ulrich Stelzl; Janice M Zengel; Marina Tovbina; Marquis Walker; Knud H Nierhaus; Lasse Lindahl; Dinshaw J Patel
Journal:  J Biol Chem       Date:  2003-05-08       Impact factor: 5.157

7.  Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing.

Authors:  Gunter Meister; Markus Landthaler; Yair Dorsett; Thomas Tuschl
Journal:  RNA       Date:  2004-03       Impact factor: 4.942

8.  Fluorescence-activated cell sorting for aptamer SELEX with cell mixtures.

Authors:  Günter Mayer; Marie-Sophie L Ahmed; Andreas Dolf; Elmar Endl; Percy A Knolle; Michael Famulok
Journal:  Nat Protoc       Date:  2010-12-02       Impact factor: 13.491

Review 9.  Twenty years hunting for sulfur in DNA.

Authors:  Shi Chen; Lianrong Wang; Zixin Deng
Journal:  Protein Cell       Date:  2010-02-07       Impact factor: 14.870

10.  RAPID FUNCTIONALIZATION AND LOADING OF SOLID SUPPORTS.

Authors:  Radhakrishnan P Iyer; John E Coughlin; Seetharamaiyer Padmanabhan
Journal:  Org Prep Proced Int       Date:  2005-06       Impact factor: 1.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.